Shares of Option Care Health OPCH remained unaffected after the company reported Q2 results.
Quarterly Results
Earnings per share increased 550.00% year over year to $0.18, which beat the estimate of $0.09.
Revenue of $860,272,000 up by 16.12% from the same period last year, which beat the estimate of $784,190,000.
Guidance
Option Care Health sees FY21 sales of $3.35 billion-$3.50 billion.
Conference Call Details
Date: Aug 03, 2021
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/r2us3rcf
Technicals
Company's 52-week high was at $22.69
Company's 52-week low was at $10.52
Price action over last quarter: Up 15.87%
Company Description
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
